Sign Up to like & get
recommendations!
0
Published in 2019 at "Biotechnology Letters"
DOI: 10.1007/s10529-019-02748-5
Abstract: Objective Thrombin, platelets, and plasmin are three key factors involved in hemostasis and thrombolysis. Thrombolytic therapy with clinically approved drugs is often followed by recurrent thrombosis caused by thrombin-induced platelet aggregation from the clot debris.…
read more here.
Keywords:
clot;
2rgd tti;
staphylokinase;
designing multifunctional ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Stroke"
DOI: 10.1161/strokeaha.122.040219
Abstract: Stroke burden is substantially increasing but current therapeutic drugs are still far from ideal. Here we highlight the vast potential of staphylokinase as an efficient, fibrin-selective, inexpensive, and evolvable thrombolytic agent. The emphasis is escalated…
read more here.
Keywords:
widely accessible;
accessible thrombolytic;
highly efficient;
staphylokinase ... See more keywords